Clik here to view.
Complex In Vitro Model: Qualification Framework Public Workshop
Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) is delighted to announce the second public workshop on evidentiary considerations for regulatory assessment and...
View ArticleClik here to view.
COA Program Concludes Successful Annual Meeting
On April 17 and 18, Critical Path Institute’s Clinical Outcome Assessment (COA) Program hosted its Annual Meeting in Rockville, MD, with more than 230 attendees, including 33 from the FDA. The annual...
View ArticleClik here to view.
Webinar: The Use and Development of DHTs with Patient Advocacy Groups
On Thursday, Mat 23 at 10:00 a.m., join C-Path and Dr. Laurent Servais of the University of Oxford and the University of Liège, for an overview of Actimyo and relevant learnings from use cases across...
View ArticleClik here to view.
TRxA BioBRIDGe Awards: Supporting the Next Generation of Protein-Based...
C-Path’s Translational Therapeutics Accelerator (TRxA) is proud to announce the 2024 global Request for Proposals for its Biologics-focused Bridging Research and Innovation in Drug Development Grants...
View ArticleClinical Outcome Assessment — Initial Public Discussion
In this presentation from C-Path’s rare and orphan disease program, you will see an overview of patient-focused drug development and endpoints that inform regulatory decision making, a summary of work...
View ArticleCritical Path for Parkinson’s Celebrates Foundational 10-year Milestone
Critical Path Institute’s Critical Path for Parkinson’s consortium is celebrating a significant 10-year milestone today. The genesis of what CPP is today took place in London during a pivotal meeting...
View ArticleClik here to view.
Beyond the Scrubs: C-Path Nurses Smith, Heavner Share Their Insights for...
In honor of National Nurses Week, C-Path sat down with its own Gina Smith, MPH, RN, and Smith Heavner, Ph.D., RN, to gain valuable insights from their experience as nurses. In this lively,...
View ArticleClik here to view.
C-Path’s International Neonatal Consortium and the National Association of...
The modules will help educate neonatal healthcare professionals in neonatal drug development, pipeline decision-making and addressing neonate needs in the current environment. TUCSON, Ariz., May 7,...
View ArticleClik here to view.
C-Path’s CDRC and xCures Partner with Lane United Football Club and hummel...
The partnership will boost sarcoma research awareness and support through a special event on May 16 and July 3 with proceeds benefiting the Northwest Sarcoma Foundation. TUCSON, Ariz., May 9, 2024 —...
View ArticleNEW FUNDING OPPORTUNITY! C-Path’s TRxA Announces its First Biologics-focused...
TUCSON, Ariz, May 15, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its inaugural biologics-focused Request for Proposals (RFP) in its...
View ArticleClik here to view.
C-Path Roundtable: Help4HD Unites to Discuss Advancements in Huntington’s...
“My husband passed away with no therapies, no treatments that worked for him, and it took away his quality of life. I am going to continue to fight so that does not happen to my children, and...
View ArticleC-Path’s RDCA-DAP Webinar, “The Use and Development of DHTs with Patient...
Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), part of C-Path’s Rare and Orphan Disease Programs, recently hosted a webinar, “The Use and Development...
View ArticleAccelerating healthcare innovation: the role of Artificial intelligence and...
Jagdeep T. Podichetty, Sakshi Sardar, Nick Henscheid, Grace V. Lee, J. Rubin Abrams, Wes Anderson, Shu Chin Ma, Klaus Romero Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are...
View ArticleClik here to view.
C-Path Supports Gleason, ALS Community at IgNight ALS
The C-Path team was incredibly humbled to be a part of IgNight ALS recently in Washington, D.C., honoring Steve Gleason and celebrating the release of his new book, A Life Impossible: Living with ALS:...
View ArticleeCOA Masterclass #1: The Road to Best Practice Consensus: Electronic...
This 1st Masterclass — the fourth installment of our eCOA Educational Series — takes a deep dive into current best practices for the electronic migration and implementation of patient-reported outcome...
View ArticleClik here to view.
Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease
C-Path’s Rare and Orphan Disease Programs is excited to have Dr. Anthony Bleyer present it’s June webinar, “Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD).” Dr....
View ArticleClik here to view.
Advocate Sarah Dolan Brings a Patient Voice to FDA Committee Reviewing New...
On Monday, June 10, the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted favorably on the evidence from clinical trials on Eli Lilly’s...
View ArticleClik here to view.
C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing...
TUCSON, Ariz., June 12, 2024 — Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology can optimize measuring symptoms important to people with...
View ArticleC-Path’s AI Collaborations Accelerate Drug Development, Improve Lives
TUCSON, Ariz., June 12, 2024 — Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and Translational Science. As the preeminent leader...
View ArticleUsing a smartwatch and smartphone to assess early Parkinson’s disease in the...
Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD). The post Using a smartwatch and smartphone to assess early Parkinson’s disease...
View Article